Difference between revisions of "Moderna v. Pfizer"
| Line 6: | Line 6: | ||
Pfizer and BioNTech’s vaccine relies on messenger RNA technology that Moderna had developed and patented years ago, including a chemical modification that avoids prompting an undesirable immune response, Moderna said in lawsuits filed [on August 26, 2022].}} | Pfizer and BioNTech’s vaccine relies on messenger RNA technology that Moderna had developed and patented years ago, including a chemical modification that avoids prompting an undesirable immune response, Moderna said in lawsuits filed [on August 26, 2022].}} | ||
| − | Pfizer and BioNTech countersued when they filed their answer to Moderna's lawsuit. Moderna alleged that the rival mRNA vaccines are so similar that it constitutes a patent infringement due to mRNA and lipid nanoparticles in both of the vaccines. Pfizer and BioNTech deny this and assert that their vaccine is “undeniably different” from Moderna's, by using a different mRNA structure and different lipids from Moderna's vaccine. | + | Pfizer and BioNTech countersued when they filed their answer to Moderna's lawsuit. Moderna alleged that the rival mRNA vaccines are so similar that it constitutes a patent infringement due to mRNA and lipid nanoparticles in both of the vaccines. Pfizer and BioNTech deny this and assert that their vaccine is “undeniably different” from Moderna's, by using a different mRNA structure and different lipids from Moderna's patented mRNA vaccine. |
| + | |||
| + | Pfizer also complains that Moderna was violating its pledge in 2020 that it refrain from enforcing any of its [[COVID vaccine]] patents while the pandemic continued. | ||
== See also == | == See also == | ||
*[[mRNA vaccine]] | *[[mRNA vaccine]] | ||
Revision as of 08:01, January 6, 2023
Moderna v. Pfizer and BioNTech is a patent infringement lawsuit filed in late August 2022.[1]
As explained by the Wall Street Journal:
| “ | Moderna Inc. sued rival Covid-19 vaccine makers Pfizer Inc. and BioNTech SE, alleging that the companies’ shot infringes on key intellectual property owned by Moderna.
Pfizer and BioNTech’s vaccine relies on messenger RNA technology that Moderna had developed and patented years ago, including a chemical modification that avoids prompting an undesirable immune response, Moderna said in lawsuits filed [on August 26, 2022]. |
” |
Pfizer and BioNTech countersued when they filed their answer to Moderna's lawsuit. Moderna alleged that the rival mRNA vaccines are so similar that it constitutes a patent infringement due to mRNA and lipid nanoparticles in both of the vaccines. Pfizer and BioNTech deny this and assert that their vaccine is “undeniably different” from Moderna's, by using a different mRNA structure and different lipids from Moderna's patented mRNA vaccine.
Pfizer also complains that Moderna was violating its pledge in 2020 that it refrain from enforcing any of its COVID vaccine patents while the pandemic continued.